Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-12

Clinical Trial Update: Trial of Oral Glutamine in Patients With Sickle Cell Anemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating oral glutamine in patients with sickle cell anemia was terminated; results were posted in May 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral glutamine (glutamine)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Anemia, Sickle Cell | Phase 2 | Status: TERMINATED | Results posted: 2010-05-12